Skip to navigation

Health Startup Fundraising

Raising capital in the health tech market
View as Markdown

Health tech fundraising is different from consumer or enterprise SaaS fundraising. Investors in health tech evaluate a broader set of risk factors — clinical, regulatory, reimbursement — alongside the standard team and market criteria.

The Health Tech Investor Landscape

Investor TypeFocusTypical Check Size
Angel investorsEarly-stage, domain expertise25K−25K-500K
Health-specific VCsDigital health, therapeutics, devices2M−2M-20M
Generalist VCsPlatform opportunities, larger rounds5M−5M-50M+
Strategic investorsPharma, health systems, payersStrategic
Grants (SBIR/STTR)Early R&D, non-dilutive100K−100K-2M

What Health Tech Investors Look For

Beyond standard startup metrics, health investors evaluate:

  • Clinical evidence: Do you have data supporting your approach?
  • Regulatory strategy: Clear pathway to clearance/approval
  • Reimbursement path: How will you get paid?
  • Go-to-market: B2B, B2C, or B2B2C? Who is the buyer?
  • Team: Health domain expertise + tech capability
  • Market timing: Regulatory tailwinds, policy changes

Pitch Deck Structure for Health Startups

A health startup pitch deck should include:

  1. Problem — Clinical and market need
  2. Solution — Product approach and innovation
  3. Clinical evidence — Existing data and validation plan
  4. Regulatory pathway — Clear timeline and strategy
  5. Market opportunity — TAM, SAM, SOM
  6. Business model — Who pays, how much, why
  7. Go-to-market — Sales strategy, partnerships
  8. Competition — Landscape positioning
  9. Team — Health + tech expertise

Non-Dilutive Funding

Grants can fund early-stage health tech development:

  • SBIR/STTR (US) : 100K−100K-2M for R&D
  • Horizon Europe: EU research funding
  • NIH grants: Health-specific research programs
  • Innovate UK: UK health tech innovation funding